Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Foresight Autonomous (FRSX) Announces Proposed ADS Offering
-
Foresight Autonomous Holdings Ltd. Announces Proposed Public Offering of American Depositary Shares
-
Vuzix Corp. (VUZI) Verizon Reseller Agreement Should Bring Meaningful Revenue - Chardan
-
ADMA Biologics (ADMA) Results Still Waiting For CRL To Be Lifted - Chardan
-
Chardan Healthcare Acquisition Corp. Securities To Commence Separate Trading
-
Krystal Biotech (KRYS) PT Raised to $57.50 at Chardan Capital Markets
-
Chardan Capital Markets Downgrades Profire Energy (PFIE) to Neutral
-
Spring Bank Pharmaceuticals (SBPH) PT Lowered to $25 at Chardan Capital Markets
-
Chardan Capital Markets Upgrades Axovant Gene Therapies Ltd. (AXGT) to Buy
-
22nd Century Group (XXII) Key Resignation Puts Pipeline In Question - Chardan
-
Seres Therapeutics to Present at Three Upcoming March Conferences
-
uniQure BV (QURE) PT Raised to $100 at Chardan Capital Markets
-
UPDATE: Chardan Capital Markets Starts Invitae Corporation (NVTA) at Buy
-
Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
-
Synlogic to Present at Investor Conferences in March
-
Chardan Capital Markets Starts Infant Bacterial Therapeutics AB (IBTB:SS) at Buy
-
Tocagen Inc. (TOCA) PT Lowered to $25 at Chardan Capital Markets
-
Chardan Capital Markets Downgrades ORBCOMM (ORBC) to Neutral
-
MeiraGTx Holdings plc (MGTX) PT Raised to $40 at Chardan Capital Markets; 3rd Investment by J&J
-
NanoViricides (NNVC) Announces $2.5 Million Financing in Registered Direct Offering of Common Stock, Warrants
-
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
-
Monocle Acquisition Corporation Announces the Separate Trading of Its Common Stock and Warrants Commencing on February 28, 2019
-
MeiraGTx Holdings plc (MGTX) Reports $80 Million Private Placement of Ordinary Shares
-
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
-
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
-
Pre-Open Stock Movers 02/25: (ONCE) (CMTA) (QURE) Higher; (MDR) (CRON) (NBR) Lower (more...)
-
Tivity Health (TVTY) PT Raised to $33 at Chardan Capital Markets
-
Chardan Capital Markets Upgrades Audentes Therapeutics (BOLD) to Buy
-
Emergent BioSolutions (EBS) PT Raised to $71 at Chardan Capital Markets
-
Wealthbridge Acquisition Limited Announces Closing of Over-Allotment Option in Connection With Its Initial Public Offering
-
Chardan Capital Markets Starts Kodiak Sciences Inc. (KOD) at Buy; Top Pick for 2019
-
Chardan Capital Markets Downgrades iRhythm Technologies (IRTC) to Neutral
-
Genius Brands Int'l (GNUS) Prices 945.9K Share Registered Direct Offering at $2.12/Sh
-
Genius Brands International Announces $2 Million Registered Direct Offering
-
Form SC 13G/A Chardan Healthcare Acqui Filed by: BOOTHBAY FUND MANAGEMENT, LLC
-
Form SC 13G/A Chardan Healthcare Acqui Filed by: RTW INVESTMENTS, LP
-
Form SC 13G Chardan Healthcare Acqui Filed by: Chardan Investments, LLC
-
Monocle Acquisition Corporation Closes $172.5 Million Initial Public Offering
-
Chardan Capital Markets Starts Wrap Technologies (WRTC) at Buy
-
The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day
-
The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day
-
Solid Biosciences (SLDB) PT Lowered to $15 at Chardan Capital Markets
-
UPDATE: Monocle Acquisition Corp. (MNCL) Prices 15M Unit IPO at $10/Unit
-
Monocle Acquisition Corporation Announces Pricing of $150 Million Initial Public Offering
-
Form 10-Q Chardan Healthcare Acqui For: Dec 31
-
Wealthbridge Acquisition Limited (HHHH) Prices 5M Share and Warrant IPO at $10/Unit
-
Wealthbridge Acquisition Limited Announces Pricing of $50 Million Initial Public Offering
-
Chardan Capital Markets Downgrades GenSight Biologics (SIGHT:FP) (GSGTF) to Neutral
-
Chardan Capital Markets Starts Evelo Biosciences Inc (EVLO) at Neutral
-
eHealth (EHTH) PT Raised to $65 at Chardan Capital Markets

